Anti-ageing Efficacy of a Cosmetic Formulation Containing NMN (2%) Versus Placebo
NCT ID: NCT04685096
Last Updated: 2021-04-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
89 participants
OBSERVATIONAL
2020-12-12
2021-04-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the Anti-aging Efficacy of a Novel Skin Health Product
NCT05300984
Anti-aging Efficacy of Food Supplement and Cosmetic Routine
NCT06932770
Efficacy of Four Topical Products to Improve Skin Longevity
NCT07118943
A Clinical Study to Evaluate Efficacy and Safety of a Cosmetic Product in the Treatment of Facial Lines
NCT04545970
Proof of Concept Anti-ageing Clinical Study in Healthy Subjects
NCT03180645
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Asian skin
Twice-daily application for 55 Days
Test product creme
twice daily application of creme containing 2% NMN
Reference creme
twice daily application of reference creme
African-American skin
Twice-daily application for 55 Days
Test product creme
twice daily application of creme containing 2% NMN
Reference creme
twice daily application of reference creme
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Test product creme
twice daily application of creme containing 2% NMN
Reference creme
twice daily application of reference creme
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject having given her free informed, written consent
* Subject willing to adhere to the protocol and study procedures
* Subject with normal frontal temperature lower than 37.5°c/100.4°F
* Subject has read and understood the information given by the investigator related to protection against Novel Coronavirus 19 and necessity to contact the investigator in case of any suspicion of COVID related manifestation (increase of frontal temperature, cough, sore muscles, weakness…) during the study
Exclusion Criteria
* Start, stop or change in hormonal treatment (including contraceptive pill) \<1.5 months
* Cutaneous pathology on the study zone (face)
* Use of topical or systemic treatment during the previous weeks liable to interfere with the assessment of the cutaneous efficacy of the study product
* Subject having undergone a surgery under general anesthesia within the previous month
* Know allergy to certain cosmetic or dermato-pharmaceutic products
* Subject having done injections on face and/or a lifting
* Excessive exposure to sunlight or UV-rays within the month preceding the study
40 Years
65 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Eurofins
INDUSTRY
LGD
INDUSTRY
Seneque SA
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Corinne BENIER
Role: STUDY_DIRECTOR
Dermscan
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Eurofins CRL Cosmetics Inc
Piscataway, New Jersey, United States
Eurofins China
Guangzhou, , China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
19E4487
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.